GlassScriptPhysician profile
Caroline L Wilds
NPI 1326253162
$2,397.47
in general payments reported to CMS, 2019-2025
36 companies · $1,040 in 2025
The $1,040 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.77 · 2020: $14.07 · 2022: $103 · 2023: $255 · 2024: $956 · 2025: $1,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,250.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $335.61 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $313.12 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $163.77 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $144.70 | 2024-2025 | Gemtesa |
| Exact Sciences Corporation | $142.80 | 2025 | The Cologuard Plus Collection Kit |
| Amgen INC. | $118.10 | 2022-2025 | Evenity, Otezla, Repatha |
| Phathom Pharmaceuticals, INC. | $111.22 | 2024-2025 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $99.66 | 2024-2025 | Breztri, Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $96.96 | 2023-2025 | Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.72 | 2024-2025 | Jardiance, Synjardy |
| Abbott Laboratories | $72.61 | 2022-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $69.85 | 2024-2025 | Capvaxive, Gardasil 9, Gardasil |
| Otsuka America Pharmaceutical, INC. | $53.04 | 2023-2024 | Rexulti, Abilify Maintena |
| Shield Therapeutics INC | $52.86 | 2024 | |
| Eisai INC. | $50.47 | 2025 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Wilds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.